Atezolizumab
Atezolizumab is a drug used to treat Breast Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma, and other conditions. Atezolizumab is being actively studied in 327 studies and prior, has been studied in 42.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Hoffmann-La Roche | Asan Medical Center | Aslaug Helland |
National Cancer Institute (NCI) | Seoul National University Hospital | Dwight Owen |
Genentech, Inc. | Samsung Medical Center | Gulam Manji |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
- Cutaneous Melanoma
- Atezolizumab
- Houston, TexasHouston Methodist Hospital
2021-12-28
Dec 28, 2021W
Not yet recruiting
- Stage II Melanoma
- Atezolizumab
- +2 more
- Duarte, California
- +5 more
2022-03-15
Mar 15, 2022H
Recruiting
- Rectal Neoplasms
- Rectal Cancer
- Radiotherapy
- +4 more
- Shanghai, ChinaZhongshan Hospital Fudan University
2022-03-28
Mar 28, 2022I
Recruiting
- Intrahepatic Cholangiocarcinoma
- Atezolizumab
- Derazantinib
- Bad Saarow, GermanyHELIOS KLinikum Bad Saarow
2022-03-29
Mar 29, 2022D
Active, not recruiting
- Breast Cancer
- Atezolizumab
- Stereotactic radiosurgery (SRS)
- Boston, MassachusettsDana-Farber Cancer Institute
2021-12-27
Dec 27, 2021M
Not yet recruiting
- Solid Tumor
- Atezolizumab
- +3 more
- Dallas, TexasThe University of Texas Southwestern Medical Center
2022-03-29
Mar 29, 2022S
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Atezolizumab
- Stanford, CaliforniaStanford University
2021-06-30
Jun 30, 2021M
Recruiting
- Hepatocellular Carcinoma
- Resectable Hepatocellular Carcinoma
- Atezolizumab
- +2 more
- Boston, MassachusettsMassachusetts General Hospital Cancer Center
2022-02-10
Feb 10, 2022G
Recruiting
- Non-squamous Non-small-cell Lung Cancer
- Tiragolumab
- +2 more
- Washington, District of ColumbiaMedStar Georgetown University Hospital
2022-02-25
Feb 25, 2022U
Active, not recruiting
- Cervical Cancer
- Atezolizumab
- Doxorubicin
- Leuven, BelgiumUZLeuven
2021-01-26
Jan 26, 2021M
Not yet recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Atezolizumab
- Cabozantinib
- Houston, TexasM D Anderson Cancer Center
2022-03-31
Mar 31, 2022D
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- Abemaciclib
- Atezolizumab
- Boston, MassachusettsDana Farber Cancer Institute
2021-09-20
Sep 20, 2021H
Recruiting
- Hepatocellular Carcinoma
- Selinexor Pill
- +2 more
- Tampa, FloridaMoffitt Cancer Center
2022-03-23
Mar 23, 2022W
Recruiting
- Extensive-stage Small Cell Lung Cancer
- Vorolanib
- Atezolizumab
- Saint Louis, MissouriWashington University School of Medicine
2021-12-09
Dec 9, 2021U
Not yet recruiting
- Squamous Cell Carcinoma
- Urinary Tract Cancer
- Atezolizumab
- (no location specified)
2021-09-07
Sep 7, 2021T
Active, not recruiting
- Breast Cancer
- Carboplatin
- Atezolizumab
- Amsterdam, Netherlands
- +3 more
2022-03-21
Mar 21, 2022U
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Atezolizumab
- Essen, GermanyUniversity Hospital Essen
2021-10-06
Oct 6, 2021H
Active, not recruiting
- Melanoma
- Atezolizumab
- Bevacizumab
- Beijing City, China
- +2 more
2022-04-07
Apr 7, 2022N
Active, not recruiting
- HER2-positive Metastatic Breast Cancer
- Central Nervous System Metastases
- ATEZOLIZUMAB
- +2 more
- Chicago, Illinois
- +1 more
2022-03-14
Mar 14, 2022G
Recruiting
- Locally Advanced Cervical Cancer
- Atezolizumab
- +2 more
- Villejuif, Val De Marne, FranceGustave Roussy
2022-02-15
Feb 15, 2022A
Recruiting
- Colorectal Cancer
- Atezolizumab
- Essen, GermanyWestdeutsches Tumorzentrum
2022-02-14
Feb 14, 2022M
Not yet recruiting
- Locally Advanced Osteosarcoma
- +4 more
- Atezolizumab
- Cabozantinib
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022I
Recruiting
- Solid Tumor
- +2 more
- ipatasertib
- Atezolizumab
- Sutton, Surrey, United KingdomRoyal Marsden Hospital NHS Foundation Trust
2022-03-31
Mar 31, 2022N
Recruiting
- Small Cell Lung Cancer Recurrent
- Atezolizumab
- Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
2022-04-04
Apr 4, 2022U
Not yet recruiting
- NSCLC Stage IV
- NSCLC, Recurrent
- Atezolizumab
- Fairway, Kansas
- +1 more
2022-01-20
Jan 20, 2022